Comparison of checkpoint responses triggered by DNA polymerase inhibition versus DNA damaging agents. [electronic resource]
- Mutation research Nov 2003
- 215-26 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
0027-5107
10.1016/j.mrfmmm.2003.08.018 doi
Antineoplastic Agents, Alkylating--pharmacology Aphidicolin--pharmacology Ataxia Telangiectasia Mutated Proteins Benzofurans Cell Cycle Proteins Checkpoint Kinase 1 Comet Assay Cyclohexanecarboxylic Acids--pharmacology Cyclohexenes DNA Damage--drug effects DNA Replication--drug effects DNA-Binding Proteins--metabolism Duocarmycins Enzyme Inhibitors--pharmacology Fibroblasts--drug effects HeLa Cells Histones--metabolism Humans Hydroxyurea--pharmacology Indoles--pharmacology Methyl Methanesulfonate--pharmacology Nucleic Acid Synthesis Inhibitors Phosphorylation--drug effects Protein Kinases--metabolism Protein Serine-Threonine Kinases--metabolism Replication Protein A S Phase--drug effects Tumor Suppressor Protein p53--metabolism Tumor Suppressor Proteins